PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.195
+0.005 (0.12%)
Mar 9, 2026, 3:37 PM EDT - Market open
PolyPid Market Cap
PolyPid has a market cap or net worth of $80.05 million as of March 9, 2026. Its market cap has increased by 161.85% in one year.
Market Cap
80.05M
Enterprise Value
70.59M
1-Year Change
161.85%
Ranking
Category
Stock Price
$4.20
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $80.05M, a decrease of -2.89%. That is a compound annual growth rate of -0.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 85.30M |
| OKYO Pharma | 85.27M |
| Verrica Pharmaceuticals | 84.91M |
| Seres Therapeutics | 82.59M |
| Pliant Therapeutics | 81.73M |
| Champions Oncology | 81.51M |
| aTyr Pharma | 80.79M |
| AN2 Therapeutics | 78.10M |